Indoco Remedies Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indoco Remedies Quarterly Results    (INDOCO)

Here are the latest quarterly results of Indoco Remedies. For more details, see the Indoco Remedies financial fact sheet and Indoco Remedies share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Indoco Remedies Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,3562,6262,5202,5272,9202,8932,7202,759 
Other income Rs m364966753 
Turnover Rs m2,3602,6312,5702,5332,9262,9012,7252,761 
Expenses Rs m2,2382,3782,2352,2992,5982,5422,3872,270 
Gross profit Rs m118248286228321351333489 
Depreciation Rs m177177195170180176182191 
Interest Rs m5037466154697858 
Profit before tax Rs m-105399439311378242 
Tax Rs m-27-14-22-1920202470 
Profit after tax Rs m-785311622739354172 
Gross profit margin %5.09.411.39.011.012.112.217.7 
Effective tax rate %26.0-36.9-23.7-678.621.317.530.928.9 
Net profit margin %-3.32.04.60.92.53.22.06.2 
Diluted EPS Rs -0.8 0.6 1.3 0.2 0.8 1.0 0.6 1.9  
Diluted EPS (TTM) Rs 2.5 0.7 -0.3 1.2 2.9 3.3 2.6 4.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Indoco Remedies 3QFY20 Result Performance Review

More Miscellaneous Company Quarterly Results:   IPCA LABS  FULFORD INDIA  BIOCON   NOVARTIS  FRESENIUS KABI ONCO.  

Compare INDOCO REMEDIES With:   IPCA LABS  FULFORD INDIA  BIOCON   NOVARTIS  FRESENIUS KABI ONCO.  

Compare INDOCO REMEDIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 110 Points Lower; Smallcap & Midcap Stocks Outperform(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower, ahead of Q2 GDP data.

Views on news

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

Stocks that Could Shine More than Gold After Diwali (Profit Hunter)

Nov 17, 2020

If the markets become volatile over the next few months, do this.

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

How to Build the Best Trading System (Fast Profits Daily)

Nov 20, 2020

In this video, I'll show you how to make the best trading system.

An Eraser and Some Pencils (The Honest Truth)

Nov 17, 2020

Ajit Dayal on the road ahead for the world after covid.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Nov 27, 2020 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - TVS SRICHAKRA COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS